The year 2020 unexpectedly became one of the most challenging for the pharmaceutical industry, as COVID-19 bared its fangs. Scientists race to find effective treatments and vaccines, while businesses grapple to find new normality in the disruption to standard working practices.
In these difficult – and sometimes dark times – it is more important than ever to recognize and reward success; to remind ourselves of the good in the world. And that’s why The Medicine Maker’s annual Power List will be back in 2021. The aim? To celebrate influential medicine makers. We want to shine a spotlight on those individuals who are contributing to the development and manufacture of new drugs, including biopharmaceuticals, small molecules and advanced therapies – whether for COVID-19 or other therapeutic areas.
For inspiration, check out the 2020 Power List available at https://themedicinemaker.com/power-list/2020.
It’s an open nomination process – and you’re free to nominate as many individuals as you like. But please note that nominations will close on February 1, 2020. Nominate at tmm.txp.to/pl2021-noms.
The Power List is divided into three categories: Small Molecules, Biopharmaceuticals, and Advanced Medicine. The final List will include 20 names per category.
Anyone involved in the development or manufacture of new medicinal products. Previous lists have featured individuals from academia, research institutes, big pharma, SMEs, start ups, societies, notfor- profit institutes, consultancies, and more. We invite nominations from all corners of the industry.
You can nominate as many individuals as you like.
Yes, if you must.
Nominations are passed to a judging panel. Judges will consider each individual’s achievements and profile in the industry.
The 2021 List will be published in the April 2021 edition of The Medicine Maker.
stephanie.sutton@texerepublishing.com
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
